Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Induction Chemotherapy
100%
Biallelic
100%
Early Treatment Failure
100%
Pediatric T-cell Acute Lymphoblastic Leukemia
100%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
75%
Lymphoblast
50%
Induction Failure
50%
DNA Polymerase Chain Reaction
50%
Working Diagnosis
50%
Clinical Application
25%
High Risk
25%
Survivors
25%
Overall Survival
25%
Cancer Institute
25%
Complete Remission
25%
Group Studies
25%
Children's Oncology Group
25%
Alternative Therapy
25%
Leukemic Cells
25%
Array Comparative Genomic Hybridization (aCGH)
25%
Prospective Clinical Trial
25%
Polymerase Chain Reaction Assay
25%
Comparative Genomic Hybridization
25%
High Probability
25%
Poor Response
25%
Thymocytes
25%
Genomic DNA (gDNA)
25%
V(D)J Recombination
25%
Copy number Analysis
25%
DNA Copy number
25%
Biallelic mutations
25%
Contemporary Therapy
25%
Long-term Events
25%
Chemotherapy Failure
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Pediatrics
100%
Induction Chemotherapy
100%
T Cell Receptor
100%
Event Free Survival
50%
DNA Polymerase
50%
Lymphoblast
50%
Polymerase Chain Reaction
50%
Malignant Neoplasm
25%
Clinical Trial
25%
Overall Survival
25%
Precursor
25%
Oncology
25%
Genomic DNA
25%
Array Comparative Genomic Hybridization
25%
Comparative Genomic Hybridization
25%
Thymocyte
25%
Gene Dosage
25%
VDJ Recombination
25%
Immunology and Microbiology
T Cell
100%
T Cell Receptor
100%
Lymphoblast
50%
Event Free Survival
50%
DNA Polymerase
50%
Polymerase Chain Reaction
50%
Overall Survival
25%
Precursor
25%
Gene Dosage
25%
Comparative Genomic Hybridization
25%
Thymocyte
25%
V(D)J Recombination
25%
Array Comparative Genomic Hybridization
25%